AzTrials
AzTrials

FrailtyASPRA-ISNCT02554994

Multifactorial Intervention on Frailty in Vulnerable Older Adults

A study testing Multifactorial intervention in people with Frailty, run by Asan Medical Center at 2 sites in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Frailty is a highly prevalent, progressive condition in older adults that is characterized by multisystem physiologic impairments and vulnerability to stressful events, leading to increased risk of geriatric conditions, disability, falls, hospitalization, and mortality. Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Frailty
What is being tested?
Multifactorial intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
187 participants
Where
2 sitesSouth Korea
Study dates
Aug 2015to Jan 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Currently living in the PyeongChang county, GangWon province, South Korea
  • Aged 65 years or older
  • Living alone or receiving Medical aid services
  • Sign informed consent

Who cannot join

  • Unable to walk 100 meters, with or without assistive devices
  • Institutionalized for the past 6 months
  • Known metastatic cancer, end-stage heart disease, end-stage renal disease
  • Moderate to severe cognitive impairment (MMSE ≤ 18)
  • Plan to move out of the current residence in the next 6 months

Trial locations and contacts

2 sites in 1 country.

South Korea2 sites
  • PyeongChang Health Center & County Hospital

    Gangwon-Do, 25377

  • Asan Medical Center

    Seoul, 05505

Other trials in South Korea

About this study

Official title: The Effect of Multifactorial Intervention on Frailty in Vulnerable Older Adults Living in Rural Communities: A Designed Delay Trial

Frailty is a highly prevalent, progressive condition in older adults that is characterized by multisystem physiologic impairments and vulnerability to stressful events, leading to increased risk of geriatric conditions, disability, falls, hospitalization, and mortality. An effective public health intervention to improve frailty in a rural aging population with limited resources remains unknown. The purpose of our study is to evaluate the effectiveness of multidimensional public health intervention to reduce frailty and related geriatric conditions in older adults in rural communities. Our hypotheses are that a multidimensional intervention consisting of group exercise, nutritional support, depression management, polypharmacy, and home safety intervention over a 6-month period will improve frailty and selected geriatric conditions in older adults who are in low socioeconomic status or living alone in a rural community. Our primary outcome is short physical performance battery at 6 month. Secondary outcomes include frailty status, nutritional status, depression, falls, sarcopenia, and health care utilization. The investigators will conduct a designed delay trial by implementing our intervention in one town for the first 6 months (intervention group), while measuring the outcomes without any intervention in another town (serving as a control group); in the following 6 months, the investigators will implement the 6-month intervention in the control town. The findings from our study will inform us to find effective public health interventions to promote healthy aging in resource-limited, rural populations.

Conditions
Frailty
Being tested
Multifactorial intervention, Usual care
Keywords
ASPRA cohort, multifactorial intervention, Medicaid services, Geriatric disorder, Short Physical Performance Battery
Medical subject headings
Frailty

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Multifactorial interventionOther

    There are six components of intervention in this study.

    • For all participants:
    1. Group exercise
    2. Nutritional supplement(commercial liquid formula will be provided every day).
    • For selected participants:
    1. Wellness visit in primary care setting, polypharmacy and multi-morbidity every month.
    2. At risk of depression(the people identified as high risk of depression would meet psychiatrist every month).
    3. Domestic safety(If there are possible hazards in participants' home, social worker provide amendments for getting rid of it).
  • Usual careOther

    Experienced nurses will visit all participants every month during 6 months of study period, and will conduct an interview and comprehensive geriatric assessments to collect information regarding physical, nutritional, mental, mood condition and health related quality of life.

    According to ASPRA cohort schedule, all participants will be assessed by the composite measurement method composed of K-FRAIL frailty scare, Mini-Nutritional Assessment Short Form(MNA-S), the Korean version of Mini-Mental State Examination(K-MMSE), Center for Epidemiological Studies depression(CES-D), EQ-5D 3 level version from EuroQol Research Foundation(EQ-5D 3 level), Short Physical Performance Battery(SPPB), and the Cardiovascular Health Study(CHS).

Study groups in NCT02554994
Study groupRoleWhat they receive
InterventionActive comparatorASPRA (Aging Study of PyeongChang Rural Area) cohort is a population-based, prospective cohort study of older adults living in PyeongChang County of South Korea. This cohort study is supported by public health center, named PyeongChang Health Center and Country Hospital managed by government, to improve the quality of aged public health services. All participants will be recruited from ASPRA cohort. After 6 months of usual care period, eligible participants are screened by characteristics of ASPRA database, and are assigned to a multifactorial intervention arm.
Receives: Other: Multifactorial intervention; Other: Usual care
usual careActive comparatorThe other participants enrolled to ASPRA cohort are acted as a control arm. The usual care according to ASPRA protocol will be maintained.
Receives: Other: Usual care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Improve the score of Short Physical performance battery

    Measured: Change in every 6 months from baseline to end of the study

Secondary outcomes (7)
  1. Improve frailty index score calculated from the Cardiovascular Health Study criteria

    Measured: Change at 6 months from baseline

  2. Frailty status by the K-FRAIL criteria

    Measured: Change at 6 months from baseline

  3. Nutritional status by Mini-Nutritional Assessment Short Form(MNA-SF)

    Measured: Change at 6 months from baseline

  4. Depressive symptoms by Center for Epidemiologic Studies Depression Scale(CES-D)

    Measured: Change in every 6 months from baseline to end of the study

  5. Occurrence of falls

    Measured: Change at 6 months from baseline

  6. Sarcopenia measured by the consensus report of the Asian Working Group

    Measured: Change in every 6 months from baseline to end of the study

  7. Health care utilization(emergency room visit and hospitalizations)

    Measured: Change at 6 months from baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Sep 2015 (estimated)
  2. Study startAug 2015
  3. Primary completionJan 2017
  4. Study completionJan 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
187 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02554994
Sponsor's protocol ID
2015-0706
Acronym
ASPRA-IS
Status last verified
Feb 2017
First submitted
17 Sep 2015
Last updated
23 Feb 2017
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Multifactorial intervention in people with Frailty, run by Asan Medical Center at 2 sites in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Feb 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Improve the score of Short Physical performance battery (time frame: Change in every 6 months from baseline to end of the study). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Feb 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in